Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Paper
Log in
Sign up
Paper
0
Paper
Conversation
Grants
Reviews
Document
Download
Flag content
0
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
Oncology
Internal Medicine
Hepatology
Show More
Authors
Won Ho
,
Qingfeng Zhu
Jennifer Durham
,
Aleksandra Popović
,
Stephanie Xavier
,
James Leatherman
,
Aditya Mohan
,
Guanglan Mo
,
Shu Zhang
,
Nicole Groß
,
Soren Charmsaz
,
Dongxia Lin
,
Derek Quong
,
Brad Wilt
,
Ihab Kamel
,
Matthew Weiss
,
Benjamin Philosophe
,
Richard Burkhart
,
William Burns
,
Chris Shubert
,
Aslam Ejaz
,
Jin He
,
Atul Deshpande
,
Ludmila Danilova
,
Genevieve Stein-O’Brien
,
Elizabeth Sugar
,
Daniel Laheru
,
Robert Anders
,
Elana Fertig
,
Elizabeth Jaffee
+28 authors
,
Mark Yarchoan
Journal
Nature Cancer
Published
Jul 29, 2021
DOI
10.1038/s43018-021-00234-4
Show more
Save
Tip
Document
Download
Flag content
0
Tip
Save
Document
Download
Flag content
Paper
Conversation
Grants
Reviews
Abstract
Paper PDF
This PDF hasn't been uploaded yet.
Do not upload any copyrighted content to the site, only open-access content.
View on External Site
or
Upload the Paper PDF